Microcap Ledger Dyadic International Inc $DYAI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Jupiter, FL
- Fiscal year end
- December 31
- Shares outstanding
- 36,438,703 [10-Q 2026-08-12]
What the company doesAI summary of filing
Dyadic International develops and licenses microbial protein production platforms, including its proprietary C1 cell line and Dapibus technology, for use in manufacturing pharmaceutical and non-pharmaceutical products. The company generates revenue from research collaborations and licensing arrangements with partners and collaborators who use its technologies to develop and commercialize products; it is dependent on a small number of research collaborations and third-party contract research organizations for its operations. The company is in a pre-revenue or early-stage development phase, with no products currently approved for commercialization, and relies on research funding, upfront license fees, milestone payments, and potential royalties from collaborators and licensees to fund its operations. [10-K 2026-03-25]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $2.07M | −$4.08M | −$3.78M | $1.43M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $3.09M | −$7.36M | −$5.70M | $4.62M | [10-K 2026-03-25] |
| FY ended Dec 2024 | $3.50M | −$5.81M | −$3.97M | $6.51M | [10-K 2026-03-25] |
- Quarterly cash burn
- −$1.89M
- Cash runway Estimate
- ~2.3 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-11 | 29,589,371 | [10-Q 2024-11-12] |
| 2025-03-26 | 30,090,661 | [10-K 2025-03-26] |
| 2025-05-13 | 30,090,661 | [10-Q 2025-05-14] |
| 2025-08-12 | 36,187,798 | [10-Q 2025-08-13] |
| 2025-11-11 | 36,187,798 | [10-Q 2025-11-12] |
| 2026-03-24 | 36,438,703 | [10-K/A 2026-04-30] |
| 2026-05-12 | 36,438,703 | [10-Q 2026-05-13] |
| 2026-08-11 | 36,438,703 | [10-Q 2026-08-12] |
- Shelf registration
- S-1 filed 2026-09-11; declared effective 2026-09-18 [S-1 2026-09-11]
Listing status
Current status: 6 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-09-25. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-09-25 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-09-25] |
| 2026-06-18 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-06-18] |
| 2026-03-30 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-03-30] |
| 2025-12-29 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-12-29] |
| 2025-07-23 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-23] |
| 2025-06-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-06-27] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-24 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 2,616 | $1.21 | [4 2026-07-24] |
| 2026-07-23 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 54,760 | $1.30 | [4 2026-07-24] |
| 2026-07-22 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 38,016 | $1.33 | [4 2026-07-24] |
| 2026-01-02 | Tchelet Ronen | grant | 18,064 | — | [4 2026-01-06] |
| 2026-01-02 | Rawson Ping Wang | grant | 29,158 | — | [4 2026-01-06] |
| 2026-01-02 | Lucy Patrick K. | exercise | 21,552 | — | [4 2026-01-06] |
| 2026-01-02 | Kaye Jack | exercise | 21,552 | — | [4 2026-01-06] |
| 2026-01-02 | Herbst Seth | exercise | 21,552 | — | [4 2026-01-06] |
| 2026-01-02 | Hazelton Joseph P | grant | 36,418 | — | [4 2026-01-06] |
| 2025-01-07 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 15,000 | $2.01 | [4 2026-07-06] |
| 2025-01-06 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 20,000 | $1.92 | [4 2026-07-06] |
| 2024-12-30 | Francisco Trust Under Agreement Dated February 28, 1996 | sell | 40,000 | $1.98 | [4 2026-07-06] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-25 | 8-K | Listing notice or transfer |
| 2026-09-18 | 424B3 | Prospectus or prospectus supplement |
| 2026-09-11 | S-1 | Registration statement |
| 2026-08-17 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-14 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-08-13 | 424B5 | Prospectus or prospectus supplement |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-08-12 | 8-K | Results of operations |
| 2026-07-24 | 8-K | Other events |
| 2026-07-06 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-22 | 8-K | Shareholder vote results |
| 2026-06-18 | 8-K | Listing notice or transfer |
Alerts for $DYAI
Email me when Dyadic International Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.